CASI - Casi Pharma spikes as FDA clears clinical trial for blood disorder therapy
2024-05-15 09:00:06 ET
More on CASI Pharmaceuticals
- CASI stock rises on positive interim data from early stage trial for its NHL treatment in China
- Seeking Alpha’s Quant Rating on CASI Pharmaceuticals
- Historical earnings data for CASI Pharmaceuticals
- Financial information for CASI Pharmaceuticals